Hydrochloric Acid

Hydrochloric Acid

SCHEMBL233973

CC=CC(=O)NCCC[N+](C)(C)C.[Cl-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.40
APEX1 P27695 2/20 0.41
KMT2A Q03164 2/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CBLB Q13191 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
ZDHHC20 Q5W0Z9 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
BBOX1 O75936 1/20 0.34
MAPT P10636 1/20 0.34
ZDHHC2 Q9UIJ5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25544701 0.98 APEX1 (0.42) APEX1ACHEKMT2AATMSMN1; SMN2
SCHEMBL1628096 0.98 APEX1 (0.42) APEX1ACHEKMT2AATMSMN1; SMN2
Sulfuric Acid SCHEMBL25230184 0.91 APEX1 (0.42) APEX1ACHEKMT2AATMSMN1; SMN2
Hydrochloric Acid SCHEMBL8777430 0.89 ACHE (0.49) APEX1ACHEKMT2AATMSMN1; SMN2
SCHEMBL20530938 0.86 ACHE (0.50) APEX1ACHEKMT2AATMSMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL25407679 0.85 APEX1 (0.38) APEX1ACHEKMT2AATMSMN1; SMN2
Hydrochloric Acid SCHEMBL11054825 0.84 KMT2A (0.42) APEX1KMT2AATMSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL22687484 0.82 APEX1 (0.40) APEX1KMT2AATMSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL3432649 0.82 ACHE (0.38) ACHEKMT2AATMALDH1A1CBLB
SCHEMBL21610956 0.82 APEX1 (0.49) APEX1KMT2ASMN1; SMN2ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12605326-B2 Cosmetic composition comprising a polymer comprising at least one cationic (meth)acrylamide unit, a particular silicone and at least one surfactant L'OREAL (FR) 2026-04-21 US claimed
EP-4171474-A1 COMPOSITION COMPRISING A PARTICULAR SILICONE EMULSION, A PARTICULAR (METH)ACRYLAMIDE POLYMER, SURFACTANTS AND A CATIONIC POLYSACCHARIDE L'OREAL (FR) 2023-05-03 EP claimed
US-20230065360-A1 COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE SURFACTANT L'OREAL (FR) 2023-03-02 US claimed
EP-3647277-A1 PROCESS FOR DEWATERING AQUEOUS SLUDGE WATER Clariant International Ltd (CH) 2020-05-06 EP claimed
EP-2720668-B1 COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT OREAL (FR) 2020-05-06 EP claimed
WO-2018199785-A1 METHOD FOR PREPARATION OF A LACTOBACILLUS RHAMNOSUS BACTERIAL BIOFILM ON A METAL SURFACE AND BIOELECTRODE OBTAINED BY THIS METHOD Uniwersytet Jagielloński (PL) 2018-11-01 WO claimed
CN-105102127-B Ion exchange membrane with specific ion permselectivity 苏特沃克技术有限公司 2018-09-18 CN claimed
US-10039706-B2 Cosmetic composition comprising at least one particular amphoteric polymer and an antidandruff agent L'OREAL (FR) 2018-08-07 US claimed
EP-2909168-B1 ACRYLAMIDE-BASED CROSSLINKING MONOMERS, THEIR PREPARATION, AND USES THEREOF SALTWORKS TECH INC (CA) 2018-05-09 EP claimed
US-9834730-B2 Use of emulsion polymers to flocculate solids in organic liquids ECOLAB USA INC. (US) 2017-12-05 US claimed
US-4814101-A AN ACRYLIC ESTER/AN ACRYLIC ACID/AN ACRYLIC QUATERNARY AMMONIUM COMPOUND TERPOLYMER; POLYAMPHOLYTES; STORAGE STABILITY; SOFTENERS; LONG-LASTING HOLD HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1989-03-21 US claimed
US-4734205-A WATER DISPERSIBLE ACRYLIC PERPOLYMER EXXON RESEARCH AND ENGINEERING COMPANY (US) 1988-03-29 US claimed
EP-0247774-A2 Cationic monomer delayed addition process EXXON CHEMICAL PATENTS INC. (US) 1987-12-02 EP claimed
US-4568731-A ADDING 1,3-DIONE MOIETIES TO ENHANCE PERFORMANCE CHARACTERISTICS AND RATES OF POLYMERIZATION AMERICAN CYANAMID COMPANY (US) 1986-02-04 US claimed
EP-0049766-B1 HIGH CONCENTRATION WATER SOLUBLE POLYMERS AS WATER-IN-OIL EMULSIONS AMERICAN CYANAMID COMPANY (US) 1985-03-27 EP claimed
US-4483959-A Organic pigments HERCULES INCORPORATED (US) 1984-11-20 US claimed
US-4404310-A GRAFT POLYMERS OF UNSATURATED COMPOUND ONTO WATER SOLUBLE CATIONIC POLYMERS HERCULES INCORPORATED (US) 1983-09-13 US claimed
US-4339371-A High concentration water-soluble polymers in water-in-oil emulsions AMERICAN CYANAMID COMPANY (US) 1982-07-13 US claimed
EP-0049766-A1 High concentration water soluble polymers as water-in-oil emulsions AMERICAN CYANAMID COMPANY (US) 1982-04-21 EP claimed
US-4311809-A WATER-INSOLUBLE CATIONIC ADDITION GRAFT POLYMERS; OPAQUE PAPER FILLERS HERCULES INCORPORATED (US) 1982-01-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10039706-B2 Cosmetic composition comprising at least one particular amphoteric polymer and an antidandruff agent ACR, KRT18, ASS1 ACHE 1997/4885APEX1 382/4885KMT2A 554/4885
US-20230065360-A1 COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE SURFACTANT KRT18, ACR, MUC1 ACHE 428/4885APEX1 1732/4885KMT2A 633/4885
US-12605326-B2 Cosmetic composition comprising a polymer comprising at least one cationic (meth)acrylamide unit, a particular silicone and at least one surfactant MSH6, KRT18, MMAB ACHE 1906/4885APEX1 1725/4885KMT2A 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.